Enanta Pharmaceuticals
ENTA
ENTA
194 hedge funds and large institutions have $1.49B invested in Enanta Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
1.87% less ownership
Funds ownership: 91.61% → 89.73% (-1.9%)
12% less capital invested
Capital invested by funds: $1.7B → $1.49B (-$212M)
63% less call options, than puts
Call options by funds: $4.51M | Put options by funds: $12.2M
Holders
194
Holding in Top 10
3
Calls
$4.51M
Puts
$12.2M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$13.5M | |
| 3 | +$5.94M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.74M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.62M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$14.4M | |
| 3 | -$8.66M | |
| 4 |
Renaissance Technologies
New York
|
-$8.03M |
| 5 |
Millennium Management
New York
|
-$7.65M |